Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

DuPont team presents new cdk inhibitors at ACS meeting

Aug. 31, 1999

Celecoxib NDA receives priority review designation for FAP

Aug. 31, 1999

Searle pays milestone to Epimmune for anticancer candidate

Aug. 31, 1999

LB-42908 inhibits protein farnesyltransferase in vitro, in vivo

Aug. 30, 1999

Preclinical studies of abetafen show potential for treatment of prostate disease

Aug. 30, 1999

Cytotoxic macrolide compounds HA-1 and TH-2 obtained from marine sources

Aug. 30, 1999

NaPro BioTherapeutics focuses on new anticancer programs

Aug. 30, 1999

NuOncology Labs awarded second U.S. patent

Aug. 30, 1999

Evacet/Taxol combination enters advanced breast cancer trials

Aug. 30, 1999

Cell Pathways seeks approval of Aptosyn in the U.S.

Aug. 27, 1999

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...